This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Biotech

Can Regulus Therapeutics Double Again on Next Hep-C Drug Trial Update?

Can Regulus Therapeutics Double Again on Next Hep-C Drug Trial Update?

New trial data from a group of hepatitis C patients treated with a higher dose of RG-101 are expected in early February, according to Regulus

01/28/15 - 02:28 PM EST

Abbot Laboratories (ABT) Stock Gains Today on $5.3 Billion Generic Business Sale Approval

  • Tickers in this article:
  • ABT

Abbot Laboratories (ABT) shares are rising after the European Commission announced its approval of the company's generic business sale to Mylan (MYL).

01/28/15 - 01:55 PM EST

Amgen (AMGN) Stock Declines Today Despite Earnings Beat

Amgen (AMGN) Stock Declines Today Despite Earnings Beat

  • Tickers in this article:
  • AMGN

Amgen (AMGN) shares are falling following the release of the company's fourth quarter earnings results today.

01/28/15 - 12:30 PM EST

Abbot Laboratories (ABT) Stock Gains Today on $5.3 Billion Generic Business Sale Approval

Abbot Laboratories (ABT) Stock Gains Today on $5.3 Billion Generic Business Sale Approval

  • Tickers in this article:
  • ABT

Abbot Laboratories (ABT) shares are rising after the European Commission announced its approval of the company's generic business sale to Mylan (MYL).

01/28/15 - 01:55 PM EST

Novartis (NVS) Stock Gains Today on Earnings Beat

Novartis (NVS) Stock Gains Today on Earnings Beat

  • Tickers in this article:
  • NVS

Novartis (NVS) shares are climbing on the company's strong fourth quarter financial performance.

01/27/15 - 04:15 PM EST

Medtronic Avoids U.S. Taxes While Saddling Shareholders With a Hefty Tax Bill

Medtronic Avoids U.S. Taxes While Saddling Shareholders With a Hefty Tax Bill

Medtronic's $49.9 billion acquisition of Covidien -- the largest tax inversion deal ever -- will leave shareholders with a big tax bill, while Medtronic may pay little or no taxes.

01/28/15 - 06:01 AM EST

Bristol-Myers Squibb (BMY) Stock Falls Today on Weak Guidance

Bristol-Myers Squibb (BMY) Stock Falls Today on Weak Guidance

  • Tickers in this article:
  • BMY

Bristol-Myers Squibb (BMY) shares are declining after it issued weak 2015 guidance today.

01/27/15 - 12:42 PM EST

Pfizer Warns on Outlook but Analysts Optimistic: What Wall Street's Saying

Pfizer Warns on Outlook but Analysts Optimistic: What Wall Street's Saying

  • Tickers in this article:
  • PFE

Pfizer was one of several blue chip companies to warn investors that foreign exchange swings would cut into sales and profit in 2015. Here's what analysts said.

01/27/15 - 12:19 PM EST

Biotech Stock Mailbag: Arena Pharma, Agenus, EnteroMedics

Biotech Stock Mailbag: Arena Pharma, Agenus, EnteroMedics

Biotech columnist Adam Feuerstein answers readers' questions about health care.

01/23/15 - 06:00 AM EST

Egalet (EGLT) Stock Gains Today on Price Target Increase

Egalet (EGLT) Stock Gains Today on Price Target Increase

  • Tickers in this article:
  • EGLT

Egalet (EGLT) shares are climbing after analysts at Canaccord Genuity raised its price target to $18 from $12 today.

01/26/15 - 09:53 AM EST

8 Biotech Stock Controversies Emerging From 'JPM15' Conference

8 Biotech Stock Controversies Emerging From 'JPM15' Conference

The J.P. Morgan Healthcare Conference is in the rear-view mirror, but issues, controversies and questions raised during the annual gathering of the biotech sector tribe will linger through the year.

01/20/15 - 10:18 AM EST

Express Scripts CEO: Amgen, Regeneron Among Targets for Drug Discounting

Express Scripts CEO: Amgen, Regeneron Among Targets for Drug Discounting

Express Scripts CEO George Paz doesn't mince words about the need to cap specialty drug pricing during his talk Tuesday at the J.P. Morgan Healthcare Conference.

01/13/15 - 12:46 PM EST

European Stocks Gain on Rise in German Investor Confidence

European Stocks Gain on Rise in German Investor Confidence

European markets rose on Tuesday as investors welcomed news of a climb in German investor confidence.

01/20/15 - 07:30 AM EST

Depomed (DEPO) Stock Gains Today on NUCYNTA Acquisition

Depomed (DEPO) Stock Gains Today on NUCYNTA Acquisition

  • Tickers in this article:
  • DEPO

Depomed (DEPO) shares are climbing after the company purchased NUCYNTA from Janssen Pharmaceuticals for $1.05 billion.

01/16/15 - 11:02 AM EST

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV

Markets

DOW 17,191.37 -195.84 -1.13%
S&P 500 2,002.16 -27.39 -1.35%
NASDAQ 4,637.9940 -43.5030 -0.93%

Brokerage Partners

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs